Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTakeda Pharmaceutical Company Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | $0.40 | $0.44 | $0.42 |
| Q2 2025 | 1 | $19.71 | $19.84 | $19.78 |
| Q3 2025 | 1 | $16.01 | $19.96 | $17.65 |
| Q4 2025 | 1 | $12.45 | $15.53 | $13.73 |
| Q1 2026 | 1 | -$26.48 | -$21.24 | -$23.42 |
| Q2 2026 | 1 | $23.94 | $29.84 | $26.40 |
| Q3 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 1 | $34.76 | $43.33 | $38.33 |
Takeda Pharmaceutical Company Limited Earnings Date And Information
Takeda Pharmaceutical Company Limited last posted its earnings results on Thursday, October 31st, 2024. The company reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.05. The company had revenue of 1,176.04 B for the quarter and had revenue of 4,263.76 B for the year. Takeda Pharmaceutical Company Limited has generated $92 earnings per share over the last year ($91.16 diluted earnings per share) and currently has a price-to-earnings ratio of 22.38. Takeda Pharmaceutical Company Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, January 30th, 2025 based on prior year's report dates.
Takeda Pharmaceutical Company Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/28/2024 | Q2 2024 | $58.14 | $1,009.04 B | $1,176.04 B | ||
| 06/28/2024 | Q1 2024 | $60.71 | $1,028.20 B | $1,207.99 B | ||
| 03/29/2024 | Q4 2023 | -$1.92 | $1,050.87 B | |||
| 12/30/2023 | Q3 2023 | $67.38 | $1,111.19 B | |||
| 09/29/2023 | Q2 2023 | -$30.68 | $1,043.09 B | |||
| 06/29/2023 | Q1 2023 | $57.51 | $1,058.62 B | |||
| 03/30/2023 | Q4 2022 | $20.03 | $956.16 B | |||
| 12/30/2022 | Q3 2022 | $76.63 | $1,096.55 B | |||
| 09/29/2022 | Q2 2022 | $39.77 | $979.79 B | $1,002.31 B | ||
| 06/29/2022 | Q1 2022 | $67.94 | $940.82 B | $972.47 B | ||
| 03/30/2022 | Q4 2021 | -$7.31 | $873.29 B | |||
| 12/30/2021 | Q3 2021 | $36.91 | $901.29 B | |||
| 09/29/2021 | Q2 2021 | $29.24 | $819.92 B | $844.82 B | ||
| 06/29/2021 | Q1 2021 | $89.08 | $860.13 B | $949.60 B | ||
| 03/30/2021 | Q4 2020 | $126.07 | $770.27 B | |||
| 12/30/2020 | Q3 2020 | $59.08 | $836.75 B | |||
| 09/29/2020 | Q2 2020 | $2.58 | $818.74 B | $788.94 B | ||
| 06/29/2020 | Q1 2020 | $52.93 | $792.86 B | $801.85 B | ||
| 03/30/2020 | Q4 2019 | $1.11 | $771.70 B | |||
| 12/30/2019 | Q3 2019 | -$20.68 | $859.32 B |
Takeda Pharmaceutical Company Limited Earnings: FAQ's
When is Takeda Pharmaceutical Company Limited's earnings date?
Takeda Pharmaceutical Company Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, January 30th, 2025 based off last year's report dates.
Did Takeda Pharmaceutical Company Limited beat their earnings estimates last
quarter?
In the previous quarter, Takeda Pharmaceutical Company Limited (:TAK) reported $0.44 earnings per share (EPS) to beat the analysts' consensus estimate of $0.39 by $0.05.
How can I listen to Takeda Pharmaceutical Company Limited's earnings conference
call?
The conference call for Takeda Pharmaceutical Company Limited's latest earnings report can be listened to online.
How can I read Takeda Pharmaceutical Company Limited's conference call transcript?
The conference call transcript for Takeda Pharmaceutical Company Limited's latest earnings report can be read online.
How much revenue does Takeda Pharmaceutical Company Limited generate each year?
Takeda Pharmaceutical Company Limited (:TAK) has a recorded annual revenue of $4,263.76 B.
How much profit does Takeda Pharmaceutical Company Limited generate each year?
Takeda Pharmaceutical Company Limited (:TAK) has a recorded net income of $4,263.76 B. Takeda Pharmaceutical Company Limited has generated $92.09 earnings per share over the last four quarters.
What is Takeda Pharmaceutical Company Limited's price-to-earnings ratio?
Takeda Pharmaceutical Company Limited (:TAK) has a price-to-earnings ratio of 22.38 and price/earnings-to-growth ratio is 0.24.